When new Covid-19 infections and hospitalizations began soaring in Louisiana in July, state health officials were struggling with data gaps that blinded them to the full threat of the Delta variant.
People who are fully vaccinated against Covid-19 appear to have a much lower likelihood of developing long Covid than unvaccinated people even when they contract the coronavirus, a study published Wednesday indicated.
As the coronavirus began pushing the nation into lockdown in March 2020, Joshua Coleman, an anti-vaccine campaigner who organizes anti-vaccine rallies, went on Facebook Live to give his followers a rallying speech. He laid out what he thought the pandemic really was: an opportunity.
“This is the one time in human history where every single human being across this country, possibly across the planet, but especially in this country, are all going to have an interest in vaccination and vaccines,” he said. “So it’s time for us to educate.”
WASHINGTON — Two of the Food and Drug Administration’s top vaccine regulators will leave the agency this fall, a development that could disrupt its work on deciding whether to recommend coronavirus vaccines for children under 12 and booster shots for the general population.
In one of the world’s largest deployments of home COVID tests, Israel is asking families to screen all children under the age of 12 before schools and kindergartens reopen on Wednesday following summer vacation.
The daily average for hospitalized Covid-19 patients in the United States is now more than 100,000 over the last week. That average is higher than in any previous surge except last winter’s, before most Americans were eligible to get vaccinated.
The influx of patients is straining hospitals and pushing health care workers to the brink as deaths have risen to an average of more than 1,000 a day for the first time since March. The seven-day average of Covid hospitalizations peaked in mid-January with nearly 140,000 people hospitalized.
Individuals vaccinated against COVID-19 with the Moderna option showcased higher antibody levels than those vaccinated with the Pfizer-BioNTech jab, according to results from a new study.
Recent Comments